I am known to some here as Mr. Sensitivity. My daughter

New Post Public Reply Private Reply Replies (2) Message Board
podcast fity4fity #7809
576
I am known to some here as Mr. Sensitivity. My daughter named me. I used to post widely on Investors Hub until the threats and bashing got out of control. Several people from this message board asked me to write a report about the Federal Circuit Court hearing last Wednesday. This is volume 2 of 2.


Now to the hearing on October 2. DECN went third in line out of four total arguments. DECN was given 15 minutes to make their case, J&J was given 15 minutes to make their rebuttal position. Finally DECN was given 5 minutes to rebut J&J’s rebuttal. DECN’s counsel, the same guy who has represented them throughout for the last 8 years, must have decided that the judges needed to hear something more or different than just an oral summary restatement of the pleadings. So, the DECN lawyer launched into a tutorial. He schooled the judges on how test strips work, something it appears none of them knew. He then discussed how J&J was totally wrong in their arguments, which was done in a tone like “how dare they.” He then pointed out that the trial judge was also wrong because he acted as if the DECN patents were already invalid when J&J had not filed to invalidate them. By the wat the statute for invalidation of the DECN patents has run. Anyway something clicked with Judge Stoll and the questions came much faster.

One of the other judges, Judge Rayna, then appeared to try to clarify some issues by making helpful claims, even though these claims were not a part of the dispute, but went directly toward the trial judge’s unfortunate actions, in effect stating a major claim about DECN’s patents. The DECN lawyer then jumped on this and explained that the arguments made by J&J and adopted by the trial judge were wrong and used an associative argument to great effect. In my humble opinion, two of the three judges looked convinced, the third judge, Judge Moore not so much. But as Meatloaf says, two out of three ain’t bad. The DECN attorney overshot his time limit by 3.5 minutes and all of the judges let him. So, the DECN lawyer was either entertaining, or his decision to run a tutorial as his presentation had great effect. I listened to the taped replay and I am not sure that the audio did service. On the tape you cannot see facial expressions. Again, two out of three ain’t bad.

Then it was J&J’s turn. J&J allowed their second chair to make the presentation. I don’t know why. Regardless the guy was not particularly good. Wilted lettuce on a nothingburger. I cannot think of one thing the guy said that would help sway a close call into his direction. The J&J lawyer was given 15 minutes, he used only 6.5 minutes. When the J&J attorney ended and took the steps toward his chair, Judge Stoll asked the lawyer directly, (I am paraphrasing) “Don’t you have any comments about what you heard this morning?” The J&J lawyer said nothing. In fact he just stood there about 2 steps from the presentation podium, then he made some sort of comment that I was unable to hear clearly or understand, and then he sat down.

DECN’s lawyer then stood up for what is called a sur-rebuttal and reiterated everything he had said previously, only this time in about 3 minutes, not 18 minutes. He was asked no further questions. After a short pregnant silence the lead judge, Judge Moore said “we will take this under advisement.” So there was no ruling from the bench, or a semi-snide comment like there was for the case heard just before DECN.

So, here is how I view it. If the judges do not Rule 36 the DECN case, and throw it out, it will go to ruling. It will take I believe until late January or early February 2020 for a ruling. Going into the courtroom, based on the performance of the J&J lawyers, I believe they thought the case would be Rule 36ed. First hurdle passed. Today the case before DECN’s case was blown out this morning. I am thinking that if by next Friday, if a Rule 36 does not emerge, the case will await a ruling.

That is not good for J&J given the performance of their lawyers, who I would think promised J&J executives a slam dunk. At the moment we do not know if it will be a J&J slam dunk, but I am thinking it won’t be. And I am thinking that if it goes to a ruling it will be a Precedential (new law) ruling. J&J knows this, so as time goes by, first the exposure period for Rule 36, and then the delay for a written ruling, the J&J lawyers might and probably will get batskit crazy. There will come a time, if DECN plays their cards right, where there will be a golden opportunity to settle the case just before Thanksgiving, but certainly before Christmas, so J&J can dispose of the little company they love to hate.

I am thinking of a settlement, depending on how badly Mr. Berman needs capital, may well be way north of $15 million and south of $50 million.This is a negotiated agreement. In settlements both sides compromise. Settlements are not like quoting and buying stock. They are ungentlemenly battles. Mr. Berman will be called all sorts of names. It will be worse than the names his shareholders call him. But, J&J may show a few cards as well depending on how bad they want to end this. They may, and probably will, provide DECN with a list of names of people that are or were DECN shareholders who helped them, and whether these people were paid. But if this case goes to trial, DECN is certain to win because the argument to decide is simple -- black or white, and the value may well be north of $100 million because J&J sold millions and millions of boxes during the "look-back" period. The guys representing J&J are alley fighters, but I have not found in my research that this firm takes cases to trial. So we will see. We will know shortly how this will develop.




Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capital Properties Faces Leadership Challenge Amid Health News

Updated Category News Views 14

Leadership Takes an Unexpected Turn at Capital Properties When the helm of a ship faces turbulence, everyone's eyes turn to the captain. In the case of Capital Properties, Inc., their captain, Chairman, CEO and President Robert H. Eder, has hit a personal snag, diagnosed with cancer but determined to steer steady despite the storm brewing within. A Glance at Capital...

Continue Reading
Ebix Relaunches A.D.A.M. SmartCare Platform for Clinicians

Updated Category News Views 63

Revolutionizing Patient Education with SmartCare When you're in the thick of things, juggling a half-dozen patients with different needs all in a day’s work, you want your tools to be as fast and straightforward as a greasy spoon diner breakfast—simple, satisfying, and utterly dependable. And Ebix is betting they've cooked up just the recipe for that with their...

Continue Reading
Parachute Health Urges HME Transformation Through Collaboration

Updated Category News Views 146

The Road to Digital Unity in HME Cranking through the gears of the healthcare industry is no mean feat, but Parachute Health seems ready to throw some fresh oil on the machine. In a landscape riddled with complexities, they're sounding the call for a more unified digital infrastructure in the Home Medical Equipment (HME) sector through their latest white paper. We're...

Continue Reading
Florida's Insurance Premiums: Why They Keep Skyrocketing

Updated Category News Views 37

What’s Driving Up These Premiums? If you’ve ever felt like your wallet gets lighter every time you pay your insurance premium, welcome to the club. It seems like the cost of insurance in Florida is like a runaway train. But don't just blame the hurricanes. Yeah, they definitely play their part, but there’s a bigger picture lurking behind those price tags. Weather...

Continue Reading
Hankook Showcases Mobility Tech at AAPEX 2026

Updated Category News Views 74

Pioneering the Future of Automotive Mobility Jumping headfirst into the fast-evolving automotive landscape, Hankook & Company Group redefined their play at the AAPEX 2026 in Las Vegas. This wasn't just another corporate display; it was a bold declaration of intent from the powerhouse triumvirate: Hankook & Company, Hanon Systems, and Hankook Tire. Convening in the...

Continue Reading
Samsung Display's Cybersecurity Milestone in Auto Sector

Updated Category News Views 36

Who would've thought we'd be tossing around terms like 'ISO certification' and 'cybersecurity' in the auto sector? Well, welcome to your new reality in 2026, where safeguarding our data is as critical as keeping engines running smoothly. Samsung Display just snagged an ISO/SAE 21434 certification along with an ENX Vehicle Cyber Security label. That's no small...

Continue Reading
Resideo's AI-Powered Pro-IQ™ Predict: HVAC Revolution

Updated Category News Views 214

Is AI the Savior for HVAC Breakdowns? You ever been stuck on a freezing night with a busted heater? It's a classic tale: equipment goes south just when you need it most. But what if someone told you AI could catch HVAC issues before they send you running for the wool socks? Enter Resideo Technologies' latest brainchild, Pro-IQ™ Predict. This isn't some run-of-the-mill...

Continue Reading
Ortho Molecular and HANS: Streamlining Functional Medicine

Updated Category News Views 130

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 143

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading
Maternal Role in Type 1 Diabetes: A Non-Genetic Angle

Updated Category News Views 75

Unveiling the Maternal Puzzle in Type 1 Diabetes So here's a stumper: how come kids of moms with type 1 diabetes dodge the disease more than kids of dads with it? Simple genes don't account for it, says a study from University of Colorado Anschutz. With nearly 7,000 kids in this research, you'd think they'd find a genetic smoking gun. Nope. It's pointing to something else...

Continue Reading

Top 5 Most Recently Viewed Articles

eHealth, Inc. Welcomes New CEO with Inducement Grants

Updated Category News Views 234

eHealth, Inc. Welcomes New Leadership with Inducement Grants eHealth, Inc. (NASDAQ: EHTH), a prominent online health insurance platform, has recently made headlines with its strategic decision to grant inducement restricted stock unit awards to Derrick Duke. This significant move comes as Duke prepares to become the new Chief Executive Officer of the company, succeeding...

Continue Reading
JPMorgan Chase & Co.'s Strategic Shareholding Insights

Updated Category News Views 226

An Overview of Major Holdings Notification The notification serves as a standard form detailing significant holdings in companies, highlighting important aspects that investors should be aware of. This notification particularly focuses on the interaction of institutional investors, such as JPMorgan Chase & Co., with the market and how their actions might affect share...

Continue Reading
Massive Blood Shortage Hits US Amid Rising Hospital Needs

Updated Category News Views 30

Blood Supply Crisis Hits Hard The current situation isn't looking good, folks. The American Red Cross has rung the alarm bells, declaring an emergency blood shortage. It seems the national blood supply took a nosedive, plunging by 25% this June alone. Now, this ain't just a small blip on the radar. Nope, it's a full-blown emergency, and it could be putting many lives at...

Continue Reading
Appian Enhances Sales Leadership to Drive AI Growth Strategies

Updated Category News Views 147

Appian Expands Leadership Team for Enhanced Growth Appian's strategic move to bolster its sales leadership is aimed at driving growth and promoting its innovative solutions. The recent appointments of three seasoned executives are set to enhance Appian's operational effectiveness and market reach. Key Appointees Join Appian’s Sales Leadership The experienced leaders...

Continue Reading
TX Rail Products Achieves Impressive 16% Revenue Growth

Updated Category News Views 99

TX Rail Products, Inc. Celebrates Strong Financial Results TX Rail Products, Inc. (OTC Markets: TXRP), a key provider of rail and rail products to the coal mining industry, short line railroads, and tunneling contractors, has reported promising financial results for its fiscal year. The company has demonstrated significant growth, marking a noteworthy milestone in its...

Continue Reading